We chose the fibrosarcoma JT8 cell line for this purpose, because we previously demonstrated that injections of VEGF-siRNA into mice bearing JT8 tumors inhibited by 70% the VEGF production, resulting in a sustained inhibition of the tumor growth [20]. This evidence concerns the gene VEGFA and neoplasm.